| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.80B | — | +7.0% |
| Cost of Revenue | $852.0M | — | +9.0% |
| R&D Expense | $117.0M | — | +3.5% |
| SG&A Expense | $476.0M | — | +16.1% |
| Operating Income | $353.0M | — | -6.1% |
| Interest Expense | $25.0M | — | -10.7% |
| Pre-tax Income | $364.0M | — | -0.8% |
| Income Tax | $59.0M | — | +20.4% |
| Net Income | $305.0M | — | -4.1% |
| EPS (Basic) | $1.08 | — | -3.6% |
| EPS (Diluted) | $1.07 | — | -3.6% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.76B | -1.7% | +19.8% |
| Accounts Receivable | $1.52B | +2.3% | +14.5% |
| Inventory | $1.06B | +3.3% | +6.2% |
| Current Assets | $4.62B | +0.5% | +12.4% |
| Total Assets | $12.81B | +0.7% | +7.5% |
| Current Liabilities | $2.23B | -4.8% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $268.0M | — | -37.8% |
| Capital Expenditures | $93.0M | — | -4.1% |
| Investing Cash Flow | -$93.0M | — | +1.1% |
| Financing Cash Flow | -$222.0M | — | -23.3% |
| Free Cash Flow | $175.0M | — | -47.6% |
| +19.5% |
| Long-term Debt | $3.05B | +0.0% | -8.9% |
| Total Liabilities | $5.91B | -1.4% | +0.3% |
| Stockholders' Equity | $6.91B | +2.5% | +14.6% |